The primal goal of Drug development is to modify chemical compounds and develop new drug formulation from that can potentially aid in improving current healthcare services. Drug development is usually made of several steps:

Discovery of a potential novel chemical compound and developing a drug formulation

Preclinical steps which test the efficacy and safety of the new drug formulation on animal models

Submission of the compound’s Investigational New Drug Application (IND) for evaluation and approval by the U.S. Food and Drug Administration (FDA).

Commence of clinical trials that are made of 3-4 stages

Filing of an New Drug Application (NDA) for the evaluation of the FDA

Approval of the NDA and Many promising drug formulation do not pass the first or second stage due to their hydrophobic character and usually require the use of toxic solvents (which then most of the times don’t pass the toxicity tests) or the use of alternative methods (which then might affect the efficacy and the Drug delivery ).

Neowater^® and the utilization of our Solubilization service opens new opportunities for the Pharma industry in the fields of Drug development , Drug delivery and drug formulation: Solubilization with less to no toxic solvent added! Compound Screening can now be more liberal in respect to Hydrophobic compounds as now the Solubilization barrier has been lowered with the introduction of Neowater^®.

Working in a field of Drug development , Do-Coop is offering a new Solubilization service for Pharma and Biotech companies to enhance bioavailability and solubility of existing and new drugs.